A Review of Drugs in Development for the Personalized Treatment of Head and Neck Squamous Cell Carcinoma

Expert Review of Precision Medicine and Drug Development - United Kingdom
doi 10.1080/23808993.2016.1208050
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Application of Molecular Targeted Therapies in the Treatment of Head and Neck Squamous Cell Carcinoma (Review)

Oncology Letters
Cancer ResearchOncology
2018English

Immunotherapy for Head and Neck Squamous Cell Carcinoma

Memo - Magazine of European Medical Oncology
OncologyHematology
2016English

Cutaneous Squamous Cell Carcinoma of the Head and Neck

Journal of Skin Cancer
DermatologyOncology
2011English

Head and Neck: Oral Squamous Cell Carcinoma

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

Targeting the Immune Microenvironment in the Treatment of Head and Neck Squamous Cell Carcinoma

Frontiers in Oncology
Cancer ResearchOncology
2019English

Evaluation of Explant Responses to STING Ligands: Personalized Immunosurgical Therapy for Head and Neck Squamous Cell Carcinoma

Cancer Research
Cancer ResearchOncology
2018English

Profile of Pembrolizumab in the Treatment of Head and Neck Squamous Cell Carcinoma: Design Development and Place in Therapy

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2017English

Elective Neck Dissection for Clinically N0 Neck in Squamous Cell Carcinoma of the Head and Neck

JOURNAL OF JAPAN SOCIETY FOR HEAD AND NECK SURGERY
1996English

Head and Neck Squamous Cell Carcinoma Survivorship Care

2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy